Date Filed | Type | Description |
10/13/2023 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
09/27/2023 |
SC 13D/A
| BRISTOL INVESTMENT FUND LTD reports a 14% stake in Prairie Operating Co. |
06/15/2023 |
SC 13D/A
| BRISTOL INVESTMENT FUND LTD reports a 14% stake in Prairie Operating Co. |
05/10/2023 |
SC 13D/A
| BRISTOL INVESTMENT FUND LTD reports a 14% stake in Prairie Operating Co. |
02/14/2023 |
SC 13D/A
| BRISTOL INVESTMENT FUND LTD reports a 21.1% stake in Creek Road Miners, Inc. |
03/02/2022 |
SC 13G/A
| BRISTOL INVESTMENT FUND LTD reports a 1.1% stake in GT Biopharma, Inc. |
02/28/2022 |
SC 13D/A
| BRISTOL INVESTMENT FUND LTD reports a 31.6% stake in Creek Road Miners, Inc. |
04/16/2021 |
SC 13G/A
| BRISTOL INVESTMENT FUND LTD reports a 4.2% stake in GT Biopharma, Inc. |
02/09/2021 |
SC 13D/A
| BRISTOL INVESTMENT FUND LTD reports a 73.9% stake in Wizard Entertainment, Inc. |
02/08/2021 |
SC 13D/A
| BRISTOL INVESTMENT FUND LTD reports a 9.8% stake in Research Solutions, Inc. |
02/08/2021 |
SC 13G/A
| BRISTOL INVESTMENT FUND LTD reports a 7.9% stake in GT Biopharma, Inc. |
06/10/2020 |
SC 13G
| BRISTOL INVESTMENT FUND LTD reports a 9.4% stake in GT Biopharma, Inc. |
05/18/2020 |
SC 13G/A
| BRISTOL INVESTMENT FUND LTD reports a 5.1% stake in GT Biopharma, Inc. |
02/04/2020 |
SC 13D/A
| BRISTOL INVESTMENT FUND LTD reports a 72.8% stake in Wizard Entertainment, Inc. |
02/04/2020 |
SC 13G/A
| BRISTOL INVESTMENT FUND LTD reports a 4.5% stake in GT Biopharma, Inc. |
02/15/2019 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
02/12/2019 |
SC 13G/A
| BRISTOL INVESTMENT FUND LTD reports a 9% stake in GT Biopharma, Inc. |
02/12/2018 |
SC 13D/A
| BRISTOL INVESTMENT FUND LTD reports a 71.2% stake in Wizard World, Inc. |
02/07/2018 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
10/10/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/10/2017 |
SC 13G/A
| BRISTOL INVESTMENT FUND LTD reports a 2.7% stake in Oxis International, Inc. |
02/10/2017 |
SC 13D/A
| BRISTOL INVESTMENT FUND LTD reports a 20.2% stake in Research Solutions, Inc. |
12/15/2016 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
04/05/2016 |
SC 13G/A
| BRISTOL INVESTMENT FUND LTD reports a 7% stake in Oxis International, Inc. |
02/12/2016 |
SC 13D/A
| BRISTOL INVESTMENT FUND LTD reports a 14.9% stake in Wizard World, Inc. |
08/07/2013 |
SC 13D/A
| Genesis Biopharma, Inc reports a 26.5% stake in Genesis Biopharma, Inc. |
07/03/2012 |
SC 13D/A
| Jaguar Mining Inc reports a 5.9% stake in Jaguar Mining Inc. |
06/08/2012 |
SC 13G/A
| Genesis Biopharma, Inc reports a 12.8% stake in Genesis Biopharma, Inc. |
02/15/2012 |
SC 13G/A
| BRISTOL INVESTMENT FUND LTD reports a 4.5% stake in Strategic American Oil Corporation |
02/15/2012 |
SC 13G/A
| BRISTOL INVESTMENT FUND LTD reports a 1% stake in Radient Pharmaceuticals Corporation |
02/15/2012 |
SC 13G/A
| BRISTOL INVESTMENT FUND LTD reports a 8.8% stake in Genesis Biopharma, Inc. |
02/14/2012 |
SC 13D/A
| BRISTOL INVESTMENT FUND LTD reports a 17.6% stake in Derycz Scientific, Inc. |
08/25/2011 |
SC 13G/A
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend] |
08/24/2011 |
SC 13G
| RADIENT PHARMACEUTICALS Corp reports a 9.9% stake in Radient Pharmaceuticals Corporation |
|